Financial results - EMASIG INTERMED SRL

Financial Summary - Emasig Intermed Srl
Unique identification code: 33511311
Registration number: J35/1987/2014
Nace: 6622
Sales - Ron
8.881
Net Profit - Ron
4.965
Employee
The most important financial indicators for the company Emasig Intermed Srl - Unique Identification Number 33511311: sales in 2023 was 8.881 euro, registering a net profit of 4.965 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati ale agentilor si broker-ilor de asigurari having the NACE code 6622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Emasig Intermed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 28.979 65.233 100.201 114.975 119.633 111.182 69.010 99.873 126.001 8.881
Total Income - EUR 28.979 65.234 100.203 114.977 119.633 111.730 69.010 104.208 126.001 9.944
Total Expenses - EUR 5.605 29.173 18.016 24.974 23.532 16.922 15.881 14.485 17.552 4.055
Gross Profit/Loss - EUR 23.374 36.061 82.187 90.003 96.101 94.808 53.130 89.724 108.449 5.889
Net Profit/Loss - EUR 22.505 34.104 81.184 88.854 94.905 93.690 52.498 88.855 107.458 4.965
Employees 1 1 2 2 2 1 1 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -92.9%, from 126.001 euro in the year 2022, to 8.881 euro in 2023. The Net Profit decreased by -102.167 euro, from 107.458 euro in 2022, to 4.965 in the last year.

Check the financial reports for the company - Emasig Intermed Srl

Rating financiar

Financial Rating -
Emasig Intermed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Emasig Intermed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Emasig Intermed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Emasig Intermed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Emasig Intermed Srl - CUI 33511311

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 14.457 11.323 8.276 5.333 2.502 0 0 0
Current Assets 23.807 58.143 78.562 88.539 181.312 114.594 86.016 94.836 109.799 5.639
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 14.502 33.642 37.190 46.564 67.421 107.764 84.815 93.601 107.423 4.960
Cash 9.305 24.501 41.372 41.975 113.891 6.830 1.201 1.235 2.376 678
Shareholders Funds 22.594 56.887 81.291 88.959 182.231 112.680 83.577 88.952 107.556 5.062
Social Capital 89 90 89 88 86 84 83 81 81 81
Debts 1.213 1.256 11.889 11.017 7.357 7.247 4.952 5.884 2.243 576
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "6622 - 6622"
CAEN Financial Year 6622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.639 euro in 2023 which includes Inventories of 0 euro, Receivables of 4.960 euro and cash availability of 678 euro.
The company's Equity was valued at 5.062 euro, while total Liabilities amounted to 576 euro. Equity decreased by -102.167 euro, from 107.556 euro in 2022, to 5.062 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Emasig Intermed Srl

Comments - Emasig Intermed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.